Literature DB >> 6607923

Intracellular processing of epidermal growth factor. II. Intracellular cleavage of the COOH-terminal region of 125I-epidermal growth factor.

S R Planck, J S Finch, B E Magun.   

Abstract

Epidermal growth factor (EGF) undergoes a specific series of alterations during the course of its binding and internalization into cultured fibroblasts. The modified EGF species can be distinguished from each other and from native EGF by their isoelectric points. We employed peptide mapping techniques to determine the nature of these alterations. We found that 125I-EGF with a pI of 4.55 was converted to a pI 4.2 species by removal of 1 or 2 amino acid moieties from the COOH-terminal end of the protein. A pI 4.35 species was generated by a trypsin-like cut between amino acid residues 48 and 49, for a total of 5 amino acid moieties removed from the native EGF. The pI 4.0 species was formed by removal of at least the COOH-terminal arginine from the pI 4.35 species. Thus, upon binding and internalization, EGF was sequentially cleaved in the COOH-terminal region. Removal of the COOH-terminal polypeptide has been shown to dramatically reduce the affinity of EGF for its receptor, raising the possibility that intracellular dissociation of EGF from its receptor may be a direct result of the intracellular processing of EGF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607923

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Stabilized complexes of epidermal growth factor and its receptor on the cell surface stimulate RNA synthesis but not mitogenesis.

Authors:  E M Wakshull; W Wharton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo.

Authors:  F Authier; G M Di Guglielmo; G M Danielsen; J J Bergeron
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

Review 3.  Physiological functions of endosomal proteolysis.

Authors:  T Berg; T Gjøen; O Bakke
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

Review 4.  Potential role of the epidermal growth factor receptor in human pancreatic cancer.

Authors:  M Korc
Journal:  Int J Pancreatol       Date:  1990 Aug-Nov

5.  Differential effects of leupeptin, monensin and colchicine on ligand degradation mediated by the two asialoglycoprotein receptor pathways in isolated rat hepatocytes.

Authors:  B L Clarke; P H Weigel
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

6.  Development and validation of two solid-phase enzyme immunoassays (ELISA) for quantitation of human epidermal growth factors (hEGFs).

Authors:  N Sizemore; R C Dudeck; C M Barksdale; G D Nordblom; W T Mueller; P McConnell; D S Wright; A Guglietta; B S Kuo
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

7.  Transepithelial transport of epidermal growth factor by absorptive cells of suckling rat ileum.

Authors:  P A Gonnella; K Siminoski; R A Murphy; M R Neutra
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

8.  Recycling of epidermal growth factor in a human pancreatic carcinoma cell line.

Authors:  M Korc; B E Magun
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

9.  Selective degradation of insulin within rat liver endosomes.

Authors:  J J Doherty; D G Kay; W H Lai; B I Posner; J J Bergeron
Journal:  J Cell Biol       Date:  1990-01       Impact factor: 10.539

10.  An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin.

Authors:  J V Garcia; B D Gehm; M R Rosner
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.